Check-Cap is a pioneering brand that is revolutionizing colorectal cancer screening and prevention. They have developed the first and only patient-friendly preparation-free test that can detect polyps before they have the chance to transform into cancer. Their innovative technology, known as the C-Scan System, allows for early intervention and cancer prevention by detecting precancerous polyps.

This is crucial because, in many cases, colorectal cancer can be prevented if detected early. Did you know that approximately 1 in 4 individuals in the average-risk screening population have benign polyps in their colon, which have the potential to become cancerous over time? With the C-Scan System, these precancerous polyps can be identified, offering a 10-year window for prevention. Colorectal cancer incidence is on the rise globally, with millions of new cases estimated each year.

Unfortunately, screening rates remain low, leaving many at risk. Check-Cap aims to change this by providing accessible and patient-friendly screening solutions. Please note that while the C-Scan System is approved in the E.

U. Check-Cap's mission is to redefine colorectal cancer screening and prevention, making it a top priority to improve global health outcomes